Postremission Consolidation by Autologous Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia in First Complete Remission (CR) and Negative Implications for Subsequent Allogeneic HCT in Second CR: A Study by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)-Reference-Cited by-同舟云学术

Postremission Consolidation by Autologous Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia in First Complete Remission (CR) and Negative Implications for Subsequent Allogeneic HCT in Second CR: A Study by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Published:2020-04 Issue:4 Volume:26 Page:659-664
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Passweg J.R.,Labopin M.,Christopeit M.,Cornelissen J.,Pabst T.,Socié G.,Russel N.,Yakoub-Agha I.,Blaise D.,Gedde-Dahl T.,Labussière-Wallet H.,Malladi R.,Forcade E.,Maury S.,Polge E.,Lanza F.,Gorin N.C.,Mohty M.,Nagler A.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference23 articles.

1. Autologous peripheral blood stem cell transplantation for acute myeloid leukemia;Vellenga;Blood,2011

2. Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually;Passweg;Bone Marrow Transplant,2016

3. Autologous stem cell transplantation in acute myelocytic leukemia;Gorin;Blood,1998

4. Autologous stem cell transplantation for adult acute leukemia in 2015: time to rethink? Present status and future prospects;Gorin;Bone Marrow Transplant,2015

5. Long term follow up of autologous hematopoietic stem cell transplantation for acute myeloid leukemia: a survey of 3567 patients in CR at two years post transplantation, from the acute leukemia working party of the EBMT;Czerw;Cancer,2016

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and Efficacy of High-Dose Chemotherapy with TreoMel 200 vs. TreoMel 140 in Acute Myeloid Leukemia Patients Undergoing Autologous Stem Cell Transplantation;Cancers;2024-05-15

2. Lower relapse incidence with haploidentical versus matched sibling or unrelated donor hematopoietic cell transplantation for core‐binding factor AML patients in CR2: A study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation;American Journal of Hematology;2024-04-24

3. A pilot study of cord blood-derived natural killer cells as maintenance therapy after autologous hematopoietic stem cell transplantation;Annals of Hematology;2023-09-29

4. Comparison of autologous, matched sibling, and alternative donor stem cell transplant outcomes for acute myeloid leukemia patients in first remission: A propensity score matching study;Hematological Oncology;2023-09-26

5. Impact of gemtuzumab ozogamicin consolidation on hematopoietic stem cells (HSCs) mobilization in AML: analysis of 20 patients;Annals of Hematology;2023-02-16